Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Scheduled, low-dose quetiapine is effective in preventing delirium in high-risk critically
ill, trauma/surgical patients. Prophylaxis also reduced ventilator duration and ICU length of
stay.
Phase:
Phase 4
Details
Lead Sponsor:
University of Tennessee Graduate School of Medicine